Haemopoietic growth factors 2: clinical applications.
Metcalf
D
D
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.
D000818:Animals; D003115:Colony-Stimulating Factors / Q000145:classification / Q000627:therapeutic use*; D004921:Erythropoietin / Q000627:therapeutic use*; D006133:Growth Substances / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D016298:Hematopoietic Cell Growth Factors; D006801:Humans; D007951:Leukemia, Myeloid / Q000097:blood / Q000188:drug therapy*; D007970:Leukopenia / Q000097:blood / Q000188:drug therapy*; D051379:Mice; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins; D004921:Erythropoietin